Related Experiment Video
Updated: Jan 20, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Association of serum growth differentiation factor 15 level with acute ischemic stroke in a Chinese population
1Department of Neurology, Shengjing Hospital of China Medical University , Shenyang , Liaoning , PR China.
Insights
Serum Growth Differentiation Factor 15 (GDF-15) levels are elevated in acute ischemic stroke (AIS) patients. Higher GDF-15 on day 7 predicts poor outcomes, indicating its prognostic value in stroke patients.
Area of Science:
- Biochemistry
- Neurology
- Cardiovascular Medicine
Background:
- Growth Differentiation Factor 15 (GDF-15), a member of the TGF-ß family, is linked to cardiovascular diseases, diabetes, and cerebrovascular disease.
- Elevated GDF-15 concentrations are potential biomarkers for various health conditions.
Purpose of the Study:
- To investigate the clinical significance of serum GDF-15 levels in Chinese patients following acute ischemic stroke (AIS).
- To assess the association between GDF-15 levels and stroke severity, and predict patient outcomes.
Main Methods:
- Compared serum GDF-15 levels between 83 AIS patients and 124 controls at admission.
- Measured GDF-15 and NIH Stroke Scale scores at admission and day 7 post-stroke.
- Utilized diffusion-weighted MRI for stroke volume calculation and modified Rankin Scale for 90-day outcome assessment.
Main Results:
- AIS patients exhibited significantly higher serum GDF-15 levels at admission compared to controls (p < .01).
- Elevated GDF-15 on day 7 correlated with poorer outcomes (p < .05) and larger stroke volumes (p < .01).
- Logistic regression revealed GDF-15 as an independent predictor of AIS (admission, p < .01) and poor 90-day outcomes (day 7, p < .05).
Conclusions:
- Serum GDF-15 at admission is independently associated with AIS in the studied population.
- Serum GDF-15 on day 7 serves as an independent predictor of 90-day outcomes after AIS.
- GDF-15 holds potential as a prognostic biomarker for acute ischemic stroke.
Abstract:
Background: Growth differentiation factor 15 (GDF-15) is a member of the transforming growth factor-ß family. Elevated GDF-15 concentrations are associated with increased risks of cardiovascular diseases, diabetes mellitus and cerebrovascular disease. Objective: This study aimed to determine the clinical significance of serum GDF-15 level after acute ischemic stroke (AIS) in a Chinese population. Methods: We compared serum GDF-15 levels between 83 AIS patients and 124 controls. At admission and on day 7, we recorded the National Institutes of Health Stroke Scale score and measured serum GDF-15 levels for AIS patients and for control patients at admission. Stroke volumes were calculated using diffusion-weighted magnetic resonance imaging performed at admission. Clinical outcomes were evaluated 90 days later using the modified Rankin Scale. Results: Serum GDF-15 level at admission was significantly higher in AIS patients than in controls (p < .01). GDF-15 level on day 7 was significantly higher in the poor outcomes group than in the good outcomes group (p < .05). Higher GDF-15 levels at admission and on day 7 were related to larger stroke volumes (p < .01). Binary logistic regression indicated that serum GDF-15 level at admission may be independently related with AIS (p < .01). Serum GDF-15 level on day 7 may independently associated with poor outcomes after AIS (p < .05). Conclusions: GDF-15 level at admission may independently related to AIS, and GDF-15 level on day 7 could independently predict outcomes at 90 days after AIS. GDF-15 may provide prognostic information after AIS in a Chinese population.
Related Concept Videos
Population Growth
Differential Leveling
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Factors Influencing Microbial Growth: pH
Factors Influencing Microbial Growth: Temperature
Factors Influencing Microbial Growth: Osmolarity

